Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	53.17	55.63	68.74	86.33	94.39	95.82
Short-Term Investments	-	-	-	-	-	2.5
Cash & Short-Term Investments	53.17	55.63	68.74	86.33	94.39	98.32
Cash Growth	-15.37%	-19.07%	-20.37%	-8.54%	-4.00%	-46.84%
Receivables	23.96	23.59	26.36	34.63	29.84	24.1
Inventory	16.92	23.81	24.43	39.77	36.01	46.21
Prepaid Expenses	5.27	5.49	7.48	8.83	8.29	8.75
Other Current Assets	-	5.13	36.31	-	-	-
Total Current Assets	99.32	113.65	163.31	169.55	168.53	177.38
Property, Plant & Equipment	65.81	64.68	65	78.98	68.56	73.23
Goodwill	8.06	7.13	7.57	7.34	7.78	8.41
Other Intangible Assets	1.66	2.49	2.58	74.6	82.38	91.16
Long-Term Deferred Tax Assets	1.25	1.18	1.49	1.45	-	-
Other Long-Term Assets	5.55	7.68	30.69	17.22	20.29	15.42
Total Assets	187.68	202.74	270.63	349.13	347.54	365.61
Accounts Payable	4.77	5.62	6.19	9.07	7.63	8.98
Accrued Expenses	8.85	11.59	11	15.96	16.13	13.21
Current Portion of Leases	1.82	1.92	1.83	2.07	1.71	1.59
Current Income Taxes Payable	-	0.06	1.24	0.81	-	-
Other Current Liabilities	0.64	4.12	10.8	-	4.32	13.09
Total Current Liabilities	16.08	23.31	31.06	27.91	29.8	36.87
Long-Term Leases	23.17	24.01	25.92	28.82	19.24	20.88
Long-Term Deferred Tax Liabilities	-	-	-	6.44	10.16	11.9
Other Long-Term Liabilities	0.76	1.43	1.39	0.4	1.26	23.56
Total Liabilities	40.01	48.75	58.37	63.57	60.45	93.21
Common Stock	0.14	0.14	0.15	0.15	0.14	0.14
Additional Paid-In Capital	89.46	88.96	90.01	81.14	67.08	55.36
Retained Earnings	62.82	71.67	128.05	210.72	225.58	221.44
Comprehensive Income & Other	-4.76	-6.78	-5.94	-6.44	-5.72	-4.54
Shareholders' Equity	147.67	153.99	212.27	285.56	287.09	272.4
Total Liabilities & Equity	187.68	202.74	270.63	349.13	347.54	365.61
Total Debt	24.99	25.93	27.74	30.89	20.95	22.46
Net Cash (Debt)	28.18	29.7	41	55.44	73.43	75.85
Net Cash Growth	-18.90%	-27.57%	-26.05%	-24.51%	-3.19%	-53.30%
Net Cash Per Share	1.94	2.02	2.80	3.81	5.02	5.33
Filing Date Shares Outstanding	14.42	14.18	14.66	14.63	14.47	14.33
Total Common Shares Outstanding	14.42	14.42	14.66	14.63	14.44	14.33
Working Capital	83.24	90.35	132.25	141.63	138.73	140.52
Book Value Per Share	10.24	10.68	14.48	19.53	19.88	19.01
Tangible Book Value	137.96	144.37	202.12	203.63	196.92	172.83
Tangible Book Value Per Share	9.57	10.01	13.79	13.92	13.64	12.06
Machinery	47	42.9	44.39	54.53	51.19	50.81
Construction In Progress	5.97	6.04	2.39	5.02	1.38	0.43
Leasehold Improvements	37.32	36.34	34.65	34.92	34.61	34.06

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q